Skip to Content

Join the 'Adlyxin' group to help and get support from people like you.

Adlyxin News

Flu Shot Key for People With Diabetes

Posted 8 Oct 2017 by Drugs.com

SUNDAY, Oct. 8, 2017 – With predictions calling for a potentially bad flu season this year, doctors are urging people – particularly those with diabetes – to get vaccinated. Many people with diabetes don't get a seasonal flu shot each year, according to the American Association of Diabetes Educators (AADE). Some people with the blood sugar disease don't realize they're at risk for flu-related ...

Heart Health Ignored by Many With Type 2 Diabetes

Posted 8 Aug 2017 by Drugs.com

TUESDAY, Aug. 8, 2017 – Taking steps to prevent heart disease is crucial for people with type 2 diabetes. But most diabetic adults in the United States aren't meeting recommended guidelines, health officials say. In a new report, researchers confirm that "cardiovascular risk reduction is critically important for the care of patients with diabetes, with or without known [heart disease or heart ...

Online Game Helps Those With Diabetes Control Blood Sugar

Posted 8 Aug 2017 by Drugs.com

TUESDAY, Aug. 8, 2017 – Here's another example of technology's evolving impact on health care. A new study found that playing an online game can help those with diabetes get better control of their blood sugar. The study included 456 U.S. Veterans Affairs diabetes patients with poor blood sugar control while on oral medications. Half played a specially designed, team-based online diabetes ...

Sanofi Receives FDA Approval of Soliqua 100/33 (insulin glargine and lixisenatide) for the Treatment of Adults with Type 2 Diabetes

Posted 22 Nov 2016 by Drugs.com

PARIS, Nov. 21, 2016 /PRNewswire-USNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved once-daily Soliqua 100/33 (insulin glargine & lixisenatide injection) 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin (less than 60 Units daily) or lixisenatide*. Soliqua 100/33 is the combination of ...

Intensive Type 2 Diabetes Treatment Can Extend Survival: Study

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Intensive management of type 2 diabetes can make a difference in how long and how well you live, even if you don't start until middle age, researchers report. People who were already at risk of type 2 diabetes complications were randomly selected to continue with their normal treatment or to be placed in an aggressive and multipronged treatment group. Two decades after ...

Adlyxin Approved for Type 2 Diabetes

Posted 1 Aug 2016 by Drugs.com

THURSDAY, July 28, 2016 – Adlyxin (lixisenatide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release. As the FDA explained, Adlyxin is a "glucagon-like peptide-1 receptor agonist" – a hormonal drug that helps control blood sugar. The drug was evaluated in clinical studies involving 5,400 people with type 2 ...

FDA OKs New Injectable Type 2 Diabetes Medication

Posted 28 Jul 2016 by Drugs.com

THURSDAY, July 28, 2016 – The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says. The once-daily injection is to be used along with diet and exercise to improve patients' blood sugar levels. The FDA reviewed 10 clinical trials on the safety and effectiveness of Adlyxin. These studies included 5,400 people with ...

Sanofi Receives FDA Approval of Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes

Posted 28 Jul 2016 by Drugs.com

PARIS, July 27, 2016 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. "The approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people ...

Ask a Question

Further Information

Related Condition Support Groups

Diabetes, Type 2

Adlyxin Patient Information at Drugs.com